Evidence map›Paper›PMID 40856042›Full record

Observational studyActa anaesthesiologica Scandinavica2025

Prospective Assessment of Clinically Relevant Fluid Balance Thresholds Associated With Postoperative Complications in Advanced Ovarian Cancer.

Emma Hasselgren, Nina Groes Kofoed, Henrik Falconer, Håkan Björne, Diana Zach, Daniel Hunde, Hemming Johansson, Mihaela Asp, Karin Thorlacius, Päivi Kannisto and 1 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Acta anaesthesiologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04065009 (A Randomized Double Blind, Multicenter Trial to Assess Time-interval Between Cytoreductive Surgery and Adjuvant Chemotherapy After Administration of Local Anesthetic Intraperitoneally/Perioperatively in Advanced Epithelial Ovarian Cancer), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04065009 phase3active not recruitingnot on this map

A Randomized Double Blind, Multicenter Trial to Assess Time-interval Between Cytoreductive Surgery and Adjuvant Chemotherapy After Administration of Local Anesthetic Intraperitoneally/Perioperatively in Advanced Epithelial Ovarian Cancer

TypeinterventionalSponsorKarolinska InstitutetRan2020 to 2028Enrolled220ConditionsAdvanced Ovarian CancerArmsRopivacaine, Saline Solution
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emma HasselgrenDepartment of Physiology and Pharmacology, Division of Anesthesiology, Karolinska Institutet, and Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-2968-2733
Nina Groes KofoedDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, and Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Henrik FalconerDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, and Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Håkan BjörneDepartment of Physiology and Pharmacology, Division of Anesthesiology, Karolinska Institutet, and Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
Diana ZachDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, and Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Daniel HundeDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, and Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.ORCID 0009-0008-5498-163X
Hemming JohanssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Mihaela AspDepartment of Clinical Science, Division of Obstetrics and Gynaecology, Lund University, and Department of Obstetrics and Gynaecology, Skåne University Hospital, Lund, Sweden.ORCID 0000-0002-2130-5132
Karin ThorlaciusDepartment of Clinical Science, Division of Anesthesia and Intensive Care, Lund University, and Department of Anesthesia and Intensive Care Skåne University Hospital, Lund, Sweden.
Päivi KannistoDepartment of Clinical Science, Division of Obstetrics and Gynaecology, Lund University, and Department of Obstetrics and Gynaecology, Skåne University Hospital, Lund, Sweden.
Sahar SalehiDepartment of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, and Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Funding

Cancerfonden 20 0245 P 03HCancerfonden 23 0627 JCIAEuropean Society of Anaesthesiology ESAIC_GR_2020_EHRadiumhemmets Forskningsfonder 194142Stockholm läns landsting 20200004Stockholm läns landsting FoUI-973310Svenska Läkaresällskapet SLS-972109
6 · The paper itself

Abstract

backgroundReliable data on optimal fluid management in the perioperative period for patients with advanced ovarian cancer undergoing cytoreductive surgery is limited. These patients often present with malignant ascites and are prone to significant fluid shifts perioperatively. For this reason, our objective was to define clinical targets for optimal fluid balance and determine whether initial ascites should be included in fluid-loss calculations by examining the association between perioperative fluid balance and major postoperative complications.

methodsThis prospective, observational study conducted in a centralized and public healthcare system setting in Sweden between 2020 and 2023 included patients with advanced ovarian cancer, > 18 years of age, scheduled for upfront cytoreductive surgery, an ASA physical status I-III with no speech/language issues. The primary outcome was major postoperative complication within 30 days of surgery. The measurements of fluid input and output, cut-offs for fluid balance, perioperative time, and postoperative complications were defined a priori. The association between fluid balance and major postoperative complications was assessed by multivariable regression, adjusted for predefined covariates, yielding odds ratios (OR) with 95% confidence intervals (CI).

resultsOf 175 enrolled patients, 162 were included in the final analysis. In the adjusted analysis, there was a significant association between fluid balance of 1750-2700 mL, OR 3.40 (95% CI 1.06-10.9; p = 0.04) and > 2700 mL, OR 3.91 (95% CI 1.33-11.5; p = 0.01) and major postoperative complications. When including initial ascites as fluid loss, a balance of > 2700 mL was associated with major postoperative complications, OR 2.59 (95% CI 1.01-6.66, p = 0.047).

conclusionAn optimal target for perioperative fluid balance to decrease the odds of major postoperative complications is suggested to be < 1750 mL. If initial ascites is included as loss in the calculation of balance, the optimal target of fluid balance is suggested to be < 2700 mL. These results provide practical clinical reference values that may assist anesthesiologists and surgical teams in optimizing perioperative fluid management in advanced ovarian cancer. EDITORIAL COMMENT: This secondary analysis of a trial ovarian cancer operative cohort assessed the relation of the estimated fluid balance over the operative day 24 h to major postoperative complications. The findings showed that the groups where the fluid balance was in the categories higher and also most positive had higher odds for having a major complication compared to the group with lowest fluid balance. Ascities fluid was an issue in this cohort, which was managed in the analysis.

trial registrationClinicalTrials.gov: NCT04065009.

Indexed as

Fluid TherapyOvarian NeoplasmsPostoperative ComplicationsWater-Electrolyte BalanceAdultAgedAscitesCytoreduction Surgical ProceduresFemaleHumansMiddle AgedProspective StudiesSweden

Identifiers

PMID40856042
PMCPMC12379113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.